blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2522233

EP2522233 - Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.02.2017
Database last updated on 05.10.2024
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG
published on 19.09.2018  [2018/38]
Applicant(s)For all designated states
Inovobiologic, Inc.
104 - 1240 Kensington Road N-W Suite 409
Calgary, Alberta T2N 4X7 / CA
[2012/46]
Inventor(s)01 / Gahler, Roland J.
3655 Bonneville Place
Burnaby British Columbia V3N 4S9 / CA
02 / Lyon, Michael
3351 Ross Road
Nanaimo British Columbia V9T 2S3 / CA
03 / Lee, Nicole
1699 Milford Avenue
Coquitlam British Columbia V3J 2V9 / CA
 [2012/49]
Representative(s)Crooks, Elizabeth Caroline, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2012/46]Crooks, Elizabeth Caroline, et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date12179590.029.07.2008
[2012/46]
Priority number, dateUS2007083061530.07.2007         Original published format: US 830615
[2012/46]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2522233
Date:14.11.2012
Language:EN
[2012/46]
Type: A3 Search report 
No.:EP2522233
Date:20.03.2013
Language:EN
[2013/12]
Type: B1 Patent specification 
No.:EP2522233
Date:13.04.2016
Language:EN
[2016/15]
Search report(s)(Supplementary) European search report - dispatched on:EP14.02.2013
ClassificationIPC:A23L33/21, A23L29/00, A23L2/52, A23L29/269, A23L29/256, A23L29/244, A23D7/005, A61K47/36, A61P3/04
[2016/13]
CPC:
A23L29/244 (EP,US); A23L29/256 (EP,US); A23L29/27 (EP,US);
A23L33/115 (EP,US); A23L33/12 (EP,US); A23L33/21 (EP,US);
A23L33/22 (EP,US); A61K31/723 (EP,US); A61P3/04 (EP);
A61P3/06 (EP); A61P3/10 (EP) (-)
Former IPC [2012/46]A23L1/308, A23L1/30, A23L2/52, A23L1/054, A23L1/0532, A23L1/0528, A23D7/005, A61K47/36, A61P3/04
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/15]
Former [2012/46]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Ballaststoffzusammensetzung umfassend glucomannan, xanthan-gummi, alginat und lipid[2015/45]
English:Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid[2012/46]
French:Composition de fibres diététiques comprenant du glucomannan, de la gomme de xanthane, de l'alginate et des lipides[2012/46]
Former [2012/46]Ballaststoffzusammensetzung umfassend Glucomannan, Xanthan-gummi, Alginat und Lipid
Examination procedure20.09.2013Amendment by applicant (claims and/or description)
20.09.2013Examination requested  [2013/44]
07.01.2014Communication of intention to grant the patent
19.05.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
11.07.2014Communication of intention to grant the patent
05.11.2014Fee for grant paid
05.11.2014Fee for publishing/printing paid
12.11.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
02.03.2015Communication of intention to grant the patent
10.07.2015Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
09.10.2015Communication of intention to grant the patent
10.02.2016Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP08783306.7  / EP2182817
Divisional application(s)EP16164971.0  / EP3090636
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.01.2014
Opposition(s)16.01.2017No opposition filed within time limit [2017/12]
Fees paidRenewal fee
07.08.2012Renewal fee patent year 03
07.08.2012Renewal fee patent year 04
07.08.2012Renewal fee patent year 05
10.07.2013Renewal fee patent year 06
14.07.2014Renewal fee patent year 07
10.07.2015Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.07.2008
AT13.04.2016
BG13.04.2016
CY13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
FI13.04.2016
HR13.04.2016
IS13.04.2016
LT13.04.2016
LV13.04.2016
MC13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
NO13.07.2016
GR14.07.2016
LU29.07.2016
CH31.07.2016
LI31.07.2016
MT31.07.2016
PT16.08.2016
[2018/38]
Former [2018/33]HU29.07.2008
AT13.04.2016
CY13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
FI13.04.2016
HR13.04.2016
IS13.04.2016
LT13.04.2016
LV13.04.2016
MC13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
NO13.07.2016
GR14.07.2016
LU29.07.2016
CH31.07.2016
LI31.07.2016
MT31.07.2016
PT16.08.2016
Former [2018/28]HU29.07.2008
AT13.04.2016
CY13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
FI13.04.2016
HR13.04.2016
LT13.04.2016
LV13.04.2016
MC13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
NO13.07.2016
GR14.07.2016
LU29.07.2016
CH31.07.2016
LI31.07.2016
PT16.08.2016
Former [2017/37]AT13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
FI13.04.2016
HR13.04.2016
LT13.04.2016
LV13.04.2016
MC13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
NO13.07.2016
GR14.07.2016
LU29.07.2016
CH31.07.2016
LI31.07.2016
PT16.08.2016
Former [2017/24]AT13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
FI13.04.2016
HR13.04.2016
LT13.04.2016
LV13.04.2016
MC13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SI13.04.2016
SK13.04.2016
NO13.07.2016
GR14.07.2016
CH31.07.2016
LI31.07.2016
PT16.08.2016
Former [2017/22]AT13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
FI13.04.2016
HR13.04.2016
LT13.04.2016
LV13.04.2016
MC13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SK13.04.2016
NO13.07.2016
GR14.07.2016
CH31.07.2016
LI31.07.2016
PT16.08.2016
Former [2017/10]AT13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
FI13.04.2016
HR13.04.2016
LT13.04.2016
LV13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
SK13.04.2016
NO13.07.2016
GR14.07.2016
PT16.08.2016
Former [2017/09]AT13.04.2016
CZ13.04.2016
DK13.04.2016
EE13.04.2016
FI13.04.2016
HR13.04.2016
LT13.04.2016
LV13.04.2016
PL13.04.2016
RO13.04.2016
SE13.04.2016
NO13.07.2016
GR14.07.2016
PT16.08.2016
Former [2017/07]AT13.04.2016
DK13.04.2016
FI13.04.2016
HR13.04.2016
LT13.04.2016
LV13.04.2016
PL13.04.2016
SE13.04.2016
NO13.07.2016
GR14.07.2016
PT16.08.2016
Former [2016/52]AT13.04.2016
FI13.04.2016
HR13.04.2016
LT13.04.2016
LV13.04.2016
PL13.04.2016
SE13.04.2016
NO13.07.2016
GR14.07.2016
PT16.08.2016
Former [2016/51]AT13.04.2016
FI13.04.2016
HR13.04.2016
LT13.04.2016
LV13.04.2016
PL13.04.2016
NO13.07.2016
GR14.07.2016
PT16.08.2016
Former [2016/50]AT13.04.2016
FI13.04.2016
HR13.04.2016
LT13.04.2016
LV13.04.2016
PL13.04.2016
NO13.07.2016
Former [2016/49]FI13.04.2016
LT13.04.2016
PL13.04.2016
NO13.07.2016
Former [2016/46]LT13.04.2016
NO13.07.2016
Documents cited:Search[I]WO2006108283  (NATURAL FACTORS NUTRITIONAL PR [CA], et al) [I] 1-9 * the whole document *;
 [I]  - VUKSAN VLADIMIR ET AL, "Viscosity rather than quantity determines lipid lowering effects of dietary fiber in individuals consuming typical North American diet", FASEB JOURNAL; EXPERIMENTAL BIOLOGY 2006 MEETING, FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, US; SAN FRANCISCO, CA, USA, (20060301), vol. 20, no. 5, Part 2, ISSN 0892-6638, page A1027, XP008146994 [I] 1-9 * the whole document *
 [A]  - KIEFER, "Novel Fiber Limits Sugar Absorption", LIFE EXTENSION, HOLLYWOOD, FL, US, (20040901), ISSN 1524-198X, pages 25 - 37, XP003002101 [A] 1-9 * the whole document *
by applicantUS2005020535
    - YIP ET AL., OBESITY RES., (2001), vol. 9, pages 341S - 347S
    - LUDWIG ET AL., PEDIATRICS, (1999), vol. 103, no. 3, page E26
    - STRACHAN ET AL., PHYSIOL. BEHAV., (2004), vol. 80, no. 5, pages 675 - 82
    - SCHULTES ET AL., J. CLIN. ENDOCRINOL. METABOL., (2003), vol. 88, no. 3, pages 1133 - 41
    - YLONEN ET AL., DIABETES CARE, (2003), vol. 26, pages 1979 - 85
    - MARCIANI ET AL., AM. J PHYSIOL. GASTROINTEST. LIVER PHYSIOL., (2001), vol. 280, pages G1227 - 33
    - PERRY & CHILTON, Chemical Engineers Handbook(5th ed.,, UNKNOWN
    - KRAUSS ET AL., CIRCULATION, (2000), vol. 1, no. 18, pages 2284 - 99
    - STEVENS ET AL., AM. J. CLIN.. NUTR., (1987), vol. 46, no. 5, pages 812 - 7
    - BLUNDELL; BURLEY, INT. J. OBES., (1987), vol. 11, no. 1, pages 9 - 25
    - HOWARTH ET AL., NUTR. REV., (2001), vol. 59, no. 5, pages 129 - 39
    - SALMERON ET AL., DIABETES CARE, (1997), vol. 20, no. 4, pages 545 - 50
    - SALMERON ET AL., JAMA, (1997), vol. 277, no. 6, pages 462 - 77
    - JENKINS ET AL., LANCET, (1967), vol. 2, no. 7999, page 1251
    - DOI ET AL., LANCET, (1979), vol. 1, no. 8123, pages 987 - 8
    - SHIMA ET AL., NUTR. REP. INT., (1982), vol. 26, pages 297 - 302
    - BRAND ET AL., DIABETES CARE, (1991), vol. 14, no. 2, pages 95 - 101
    - WOLEVER ET AL., DIABET. MED., (1992), vol. 9, no. 5, pages 451 - 8
    - JENKINS ET AL., LANCET, (1977), vol. 2, no. 8042, pages 779 - 80
    - ARO ET AL., DIABETOLOGIA, (1981), vol. 21, no. 1, pages 29 - 33
    - VUKSAN ET AL., DIABETES CARE, (2000), vol. 23, no. 1, pages 9 - 14
    - CHIASSON ET AL., DIABETES CARE, (1996), vol. 19, no. 11, pages 1190 - 3
    - FROST ET AL., METABOLISM, (1998), vol. 47, no. 10, pages 1245 - 51
    - MEYER, ANN. NYACAD. SCI., (1955), vol. 63, pages 15 - 32
    - PENICAUD ET AL., CURR. OPIN. CLIN. NUTR. METAB. CARE, (2002), vol. 5, no. 5, pages 539 - 43
    - MATSUDA; DEFRONZO, DIABETES CARE, (1999), vol. 22, pages 1462 - 70
    - SHAMLIYAN ET AL., J FAM. PRACT., (2006), vol. 55, pages 761 - 9
    - JENKINS ET AL., AM. J. CLIN. NUTR., (2006), vol. 83, pages 582 - 91
    - RITISHAUSER, SWISS MED. WKLY, (2006), vol. 136, pages 41 - 9
    - KUO ET AL., INT. J. CLIN. PRACT, (2006), vol. 60, no. 8, pages 906 - 10
    - DIXON, AUSTRALIAN FAM. PHYS., (2006), vol. 35, pages 576 - 79
    - FERRARO ET AL., J. CLIN. INVEST., (1992), vol. 90, pages 780 - 784
    - VILLAREAL ET AL., AM. J. CLIN. NUTR., (2005), vol. 82, pages 923 - 34
    - POLANSKY ET AL., J. CLIN. INVESTIG., (1998), vol. 28, no. 2, pages 3 - 6
    - LAMOUNIER-ZEPTER ET AL., BEST PRACT. RES. CLIN. ENDOCRIN. METABOL., (2006), vol. 20, pages 355 - 367
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.